Table 2. Clinicopathologic differences based on age at diagnosis.
| Characteristics | Age groups | P-value | |||
|---|---|---|---|---|---|
| ≤50 (n=115) | 51–60 (n=119) | ≥61 (n=158) | |||
| FIGO stage | 0.015 | ||||
| IIB | 88 (76.5) | 70 (58.8) | 108 (68.4) | ||
| IIIA, IIIB, IVA | 27 (23.5) | 49 (41.2) | 50 (31.6) | ||
| Tumor size (mm) | 0.008 | ||||
| ≤50 | 57 (49.6) | 63 (52.9) | 105 (66.9) | ||
| >50 | 58 (50.4) | 56 (47.1) | 52 (33.1) | ||
| Histology | 0.820 | ||||
| SCC | 106 (92.2) | 112 (94.1) | 148 (93.7) | ||
| Others | 9 (7.8) | 7 (5.9) | 10 (6.3) | ||
| LN metastasis | <0.001 | ||||
| No | 31 (27.0) | 38 (31.9) | 89 (56.3) | ||
| Yes | 84 (73.0) | 81 (68.1) | 69 (43.7) | ||
| Treatment | <0.001 | ||||
| CCRT | 103 (89.6) | 102 (85.7) | 89 (56.3) | ||
| RT only | 12 (10.4) | 17 (14.3) | 69 (43.7) | ||
| Treatment result | 0.017 | ||||
| CR | 96 (83.5) | 109 (91.6) | 148 (93.7) | ||
| PD | 19 (16.5) | 10 (8.4) | 10 (6.3) | ||
Data are presented as number (%).
FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; LN, lymph node; CCRT, concurrent chemoradiotherapy; RT, radiotherapy; CR, complete remission; PD, persistent disease.